课题基金 / 基金详情

SARS-CoV Mediated Modulation of Innate Immunity

SARS-CoV Mediated Modulation of Innate Immunity
SARS-CoV 介导的先天免疫调节
批准号:
6997685
负责人:
Matthew Bryan Frieman
金额:
$4.4万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2008-07-31

项目摘要

项目成果

Matthew Bryan Frieman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Severe acute respiratory syndrome (SARS) is a potentially fatal disease that appears to have originated in the Guandong Province of China in the fall of 2002. The disease is caused by a new human coronavirus (CoV), named the SARS-CoV, which is unlike any previous known coronavirus, but classified among the group II coronaviruses like MHV. The goals of this proposal include the systematic deletion of each accessory ORF singly and then in combinations of the accessory ORFs of the SARS-CoV. I will use these deletion mutants to test the hypothesis that one or more accessory ORFs are responsible for modulating the host innate immune response. I will analyze the anti-viral response in Caco2, MA104 and Human Airway Epithelial (HAE) cells to establish at what level in the anti-viral pathway the interferon-antagonist proteins of SARS are acting, as well as how mutants in these SARS genes effect pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Coronavirus Challenge Core
  • 批准号:
    10420513
  • 项目类别:
  • 资助金额:
    $144.15万
  • 财政年份:
    2022
  • 负责人:
    Matthew Bryan Frieman
  • 依托单位:
Broad Spectrum Anti-viral Compounds Targeting the SKI Complex
  • 批准号:
    10183158
  • 项目类别:
  • 资助金额:
    $19.31万
  • 财政年份:
    2020
  • 负责人:
    Matthew Bryan Frieman
  • 依托单位:
Role of Diabetes in MERS Coronavirus Pathogenesis
  • 批准号:
    10649491
  • 项目类别:
  • 资助金额:
    $55.08万
  • 财政年份:
    2020
  • 负责人:
    Matthew Bryan Frieman
  • 依托单位:
Role of Diabetes in MERS Coronavirus Pathogenesis
  • 批准号:
    10196973
  • 项目类别:
  • 资助金额:
    $55.69万
  • 财政年份:
    2020
  • 负责人:
    Matthew Bryan Frieman
  • 依托单位:
国内基金
海外基金
KCTD10对2型免疫反应(Th2)的调控研究
  • 批准号:
    2020JJ4441
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    任凯群
  • 依托单位:
IL-6受体泛素化调控机制
  • 批准号:
    32070775
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    李姝
  • 依托单位:
乙烯合酶ACS家族的AEF蛋白调节拟南芥开花时间的机制研究
  • 批准号:
    31970735
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    江静
  • 依托单位:
USP13调控IL-18诱导的NF-κB活化的分子机制研究
  • 批准号:
    31900556
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2019
  • 负责人:
    林恒
  • 依托单位: